Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|September 9, 2013

VWR International, Thermo Fisher Sign Global Agreement

VWR International has signed a global distribution agreement with Thermo Fisher Scientific.

p>VWR International, a provider of laboratory supplies, equipment and services, has signed a global distribution agreement with Thermo Fisher Scientific.

Thermo Fisher represents one of VWR's most important global suppliers with products supporting all of VWR's customer segments, including pharmaceutical, biotech, industrial, educational, governmental and healthcare.


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.